Skip to main content
. 2023 Dec 1;15(23):4995. doi: 10.3390/nu15234995

Table 1.

Pre-pregnancy and pregnancy characteristics of women included in the San Carlos GDM Prevention Cohort eligible for the postdelivery program.

Non-Participants (n = 1129) Participants
(n = 1400)
p
Sociodemographic features
Age (years) 32.1 ± 5.5 33.1 ± 4.9 0.001
Ethnicity
Caucasian 724 (64.1) 935 (66.8)
Latin American 364 (32.2) 430 (30.7)
Others 41 (3.6) 35 (2.5) 0.040
University degree 683 (60.5) 964 (68.9) 0.001
Workers 839 (74.3) 1134 (81.0) 0.001
Smoking status
Never smokers 604 (53.5) 801 (57.2)
Current smokers 113 (10.0) 95 (6.8) 0.001
Pregnancies
First 458 (40.6) 625 (44.6)
Second 347 (30.7) 415 (29.6)
Third or above 324 (28.7) 360 (25.7) 0.251
In a previous pregnancy:
GDM 37 (3.3) 48 (3.4) 0.535
Miscarriage 417 (36.9) 458 (32.7) 0.018
Family history of some components of MetS 463 (41.0) 603 (43.1) 0.130
Pre-pregnancy features
Body weight (kg) 61.9 ± 11.4 61.7 ± 11.2 0.655
BMI (kg/m2) 23.4 ± 4.0 23.4 ± 4.0 0.896
Questionnaires (scores)
Nutrition 0.1 ± 3.2 0.5 ± 3.1 0.003
MEDAS 4.8 ± 1.7 5.0 ± 1.8 0.016
Physical activity −1.8 ± 1.0 −1.9 ± 1.0 0.441
Pregnancy and delivery features
SBP (mmHg) (8–12 GWs) 109 ± 10 109 ± 10 0.167
DBP (mmHg) (8–12 GWs) 67 ± 9 67 ± 9 0.613
FSG (mg/dL) (8–12 GWs) 80 ± 6 80 ± 6 0.560
HbA1 c (%) (8–12 GWs) 5.1 ± 0.3 5.2 ± 0.2 0.181
HOMA-IR (8–12 GWs) 1.2 ± 1.4 1.1 ± 1.3 0.126
Triglycerides (mg/dL) (8–12 GWs) 80 ± 33 82 ± 41 0.901
GDM (24–28 w) 172 (15.2) 289 (20.6) <0.001
Bodyweight gain (24 GWs) 7.4 ± 4.8 7.1 ± 4.1 0.176
Bodyweight gain (38 GWs) 11.7 ± 6.7 11.8 ± 6.3 0.863
Insulin treatment 40 (23.3) 70 (24.2) 0.432
High BP or preeclampsia 45 (4.0) 53 (3.8) 0.960
Prematurity (<37 GWs) 40 (3.5) 90 (6.4) 0.001
Cesarean section 244 (21.6) 296 (21.2) 0.740
LGA (>90 percentile) 42 (3.7) 50 (3.6) 0.471
SGA (<10 percentile) 34 (3.0) 80 (5.7) 0.001

Data are shown as mean ± standard deviation for quantitative variables or number (%) for qualitative variables. Statistical significance at p < 0.05. BMI, body mass index; BP, blood pressure; DBP, diastolic blood pressure; FSG, fasting serum glucose; GDM, gestational diabetes mellitus; HbA1c, glycated hemoglobin; HDL-c, high-density lipoprotein cholesterol; HOMA-IR, homeostatic model assessment–insulin resistance; LGA, large for gestational age, and SGA, small for gestational age (both according to local tables, Hospital Clinic, Barcelona, 2014); MEDAS, Mediterranean Diet Adherence Screener; MetS, metabolic syndrome; SBP, systolic blood pressure; GWs, gestational weeks.